• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于中风患者及血栓栓塞事件高危患者口服抗凝治疗的知识。

Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events.

作者信息

Alphonsa Annu, Sharma Kamlesh K, Sharma Gautam, Bhatia Rohit

机构信息

College of Nursing, All India Institute of Medical Sciences, New Delhi, India.

Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

J Stroke Cerebrovasc Dis. 2015 Mar;24(3):668-72. doi: 10.1016/j.jstrokecerebrovasdis.2014.11.007. Epub 2015 Jan 7.

DOI:10.1016/j.jstrokecerebrovasdis.2014.11.007
PMID:25577429
Abstract

BACKGROUND

Apart from atrial fibrillation, indications for oral anticoagulation common in our clinical practice include rheumatic heart disease and mechanical heart valve replacement. Evaluation of current patient knowledge regarding oral anticoagulation therapy (OAT) is the first step in improving the quality of anticoagulation therapy and patient care. The aim of the present study was to assess the knowledge regarding OAT among patients with stroke and those at high risk of thromboembolic events in a tertiary care hospital in India.

METHODS

A descriptive cross-sectional design was used; 240 patients on OAT because of various indications (mechanical heart valve replacement, rheumatic heart disease, atrial fibrillation, and stroke) attending the neurology and cardiology outpatient clinics and inpatient services were recruited. A structured self-developed questionnaire was used to assess the knowledge in these patients.

RESULTS

Most patients (62.9%) were ignorant about the target prothrombin time/international normalized ratio (PT/INR) levels with only 30% having their recent INR within the target range; 50% of the patients had a poor knowledge score, and the knowledge gap was most prominent in the domains of dietary interactions followed by drug interactions, adverse effects, and PT/INR monitoring. Knowledge score also had a significant association with gender, education, monthly income, and place of residence (P < .05).

CONCLUSION

Patient's knowledge about OAT was suboptimal. The findings support the need for educational interventions to improve the knowledge regarding OAT and, thereby, achieve an appropriate and safe secondary prevention of stroke.

摘要

背景

除心房颤动外,在我们的临床实践中,口服抗凝治疗的常见适应证包括风湿性心脏病和机械心脏瓣膜置换术。评估当前患者关于口服抗凝治疗(OAT)的知识是提高抗凝治疗质量和患者护理水平的第一步。本研究的目的是评估印度一家三级护理医院中中风患者及血栓栓塞事件高危患者对OAT的了解情况。

方法

采用描述性横断面设计;招募了240名因各种适应证(机械心脏瓣膜置换术、风湿性心脏病、心房颤动和中风)而接受OAT治疗的患者,这些患者来自神经内科和心内科门诊及住院部。使用一份自行编制的结构化问卷来评估这些患者的知识水平。

结果

大多数患者(62.9%)对目标凝血酶原时间/国际标准化比值(PT/INR)水平一无所知,只有30%的患者最近的INR在目标范围内;50%的患者知识得分较低,知识差距在饮食相互作用领域最为突出,其次是药物相互作用、不良反应和PT/INR监测。知识得分还与性别、教育程度、月收入和居住地点显著相关(P < .05)。

结论

患者对OAT的了解情况欠佳。这些发现支持了开展教育干预措施的必要性,以提高对OAT的了解,从而实现对中风的适当且安全的二级预防。

相似文献

1
Knowledge regarding oral anticoagulation therapy among patients with stroke and those at high risk of thromboembolic events.关于中风患者及血栓栓塞事件高危患者口服抗凝治疗的知识。
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):668-72. doi: 10.1016/j.jstrokecerebrovasdis.2014.11.007. Epub 2015 Jan 7.
2
Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association.欧洲心房颤动患者对口服抗凝治疗的态度、教育程度及知识差异:欧洲心律协会开展的一项患者自我评估调查结果
Europace. 2016 Mar;18(3):463-7. doi: 10.1093/europace/euv448. Epub 2016 Feb 21.
3
Thromboembolic and/or bleeding complications in patients under oral anticoagulation followed at a tertiary hospital.在一家三级医院接受随访的口服抗凝治疗患者中的血栓栓塞和/或出血并发症。
Rev Port Cardiol. 2005 Jul-Aug;24(7-8):957-68.
4
Aniticoagulation in patients following prosthetic heart valve replacement.人工心脏瓣膜置换术后患者的抗凝治疗
Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):10-7.
5
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).非瓣膜性心房颤动患者停用利伐沙班与华法林的结局:ROCKET AF 试验(利伐沙班每日 1 次口服、直接 Xa 因子抑制剂与维生素 K 拮抗剂预防心房颤动卒中及栓塞的随机临床试验)分析。
J Am Coll Cardiol. 2013 Feb 12;61(6):651-8. doi: 10.1016/j.jacc.2012.09.057.
6
Management of oral anticoagulant treatment in patients with venous thromboembolism.静脉血栓栓塞症患者的口服抗凝治疗管理
Semin Thromb Hemost. 2006 Nov;32(8):781-6. doi: 10.1055/s-2006-955460.
7
Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.老年人口服抗凝治疗的自我管理:理论依据、设计、基线情况及随访一年后的口服抗凝控制。一项随机对照试验。
Thromb Haemost. 2007 Mar;97(3):408-16.
8
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.机械人工心脏瓣膜:抗凝质量与血栓栓塞风险。多中心观察性 PLECTRUM 研究。
Int J Cardiol. 2018 Sep 15;267:68-73. doi: 10.1016/j.ijcard.2018.04.042.
9
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.心房颤动患者抗凝治疗的教育与行为干预措施
Cochrane Database Syst Rev. 2013 Jun 4(6):CD008600. doi: 10.1002/14651858.CD008600.pub2.
10
Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists.在接受维生素K拮抗剂治疗的非瓣膜性心房颤动患者真实世界队列中,评估SAMe-TT2R2风险评分预测抗凝控制质量的情况。
Europace. 2015 May;17(5):711-7. doi: 10.1093/europace/euu353. Epub 2015 Feb 5.

引用本文的文献

1
Knowledge, Adherence, and Satisfaction With Warfarin Therapy and Associated Factors Among Outpatients at University Teaching Hospital in Ethiopia.在埃塞俄比亚的大学教学医院,门诊患者对华法林治疗的知识、依从性和满意度及其相关因素。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241260736. doi: 10.1177/10760296241260736.
2
Mechanical valve replacement for patients with rheumatic heart disease: the reality of INR control in Africa and beyond.风湿性心脏病患者的机械瓣膜置换术:非洲及其他地区国际标准化比值(INR)控制的实际情况
Front Cardiovasc Med. 2024 Feb 9;11:1347838. doi: 10.3389/fcvm.2024.1347838. eCollection 2024.
3
Assessment of Oral Health Education with the Simplified Oral Hygiene Index in Military Students - A Comparative Study.
评估军事学员口腔卫生教育的简化口腔卫生指数——一项比较研究。
Oral Health Prev Dent. 2021 Sep 11;19:425-431. doi: 10.3290/j.ohpd.b1993907.
4
Validation of a Knowledge Test in Turkish Patients on Warfarin Therapy at an Ambulatory Anticoagulation Clinic.土耳其患者在门诊抗凝诊所接受华法林治疗知识测试的验证
Turk J Pharm Sci. 2021 Sep 1;18(4):445-451. doi: 10.4274/tjps.galenos.2020.88319.
5
A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs).一线希望:低收入和中等收入国家的心脏手术
Cardiovasc Diagn Ther. 2020 Apr;10(2):336-349. doi: 10.21037/cdt.2019.11.03.
6
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India.SARS-CoV-2/COVID-19 大流行与印度卒中医疗面临的挑战。
Ann N Y Acad Sci. 2020 Aug;1473(1):3-10. doi: 10.1111/nyas.14379. Epub 2020 May 12.
7
Validation of a questionnaire measuring patient knowledge of atrial fibrillation in an Asian cohort.一份测量亚洲队列中心房颤动患者知识水平的问卷的验证。
Heart Asia. 2019 Apr 24;11(1):e011143. doi: 10.1136/heartasia-2018-011143. eCollection 2019.
8
Knowledge and information levels and adherence to oral anticoagulant therapy with warfarin in patients attending primary health care services.基层医疗服务机构患者对华法林口服抗凝治疗的知识与信息水平及依从性
J Vasc Bras. 2018 Apr-Jun;17(2):109-116. doi: 10.1590/1677-5449.012017.
9
Relation between health literacy, self-care and adherence to treatment with oral anticoagulants in adults: a narrative systematic review.健康素养、自我护理与成年人口服抗凝剂治疗依从性的关系:叙事系统评价。
BMC Public Health. 2018 Oct 4;18(1):1157. doi: 10.1186/s12889-018-6070-9.
10
Patients' knowledge on oral anticoagulant treatment in Hungary.匈牙利患者对口服抗凝治疗的了解情况。
Int J Clin Pharm. 2017 Dec;39(6):1265-1272. doi: 10.1007/s11096-017-0544-1. Epub 2017 Oct 19.